Brief: Larimar Therapeutics Reports Fourth Quarter And Full Year 2022 Operating And Financial Results

Larimar Therapeutics

14/03/2023 11:14

March 14 (Reuters) - Larimar Therapeutics Inc  LRMR.O :
    * LARIMAR THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
OPERATING AND FINANCIAL RESULTS
    * CASH AND INVESTMENTS OF $118.4 MILLION AT DECEMBER 31,
2022
PROVIDES PROJECTED CASH RUNWAY INTO 2H 2024
    * AS OF DECEMBER 31, 2022, CO HAD CASH, CASH EQUIVALENTS &
MARKETABLE SECURITIES TOTALING $118.4 MILLION
    * QTRLY LOSS PER SHARE $0.21
    * Q4 EARNINGS PER SHARE VIEW $-0.37 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX1xt97K 
Further company coverage:  LRMR.O 

 ((Reuters.Briefs@thomsonreuters.com;;))